BACKGROUND: Striatal-enriched protein tyrosine phosphatase (STEP) is a brain-specific protein tyrosine phosphatase that opposes the development of synaptic strengthening and the consolidation of fear memories. In contrast, stress facilitates fear memory formation, potentially by activating corticotrophin releasing factor (CRF) neurons in the anterolateral cell group of the bed nucleus of the stria terminalis (BNSTALG). METHODS: Here, using dual-immunofluorescence, single-cell reverse transcriptase polymerase chain reaction, quantitative reverse transcriptase polymerase chain reaction, Western blot, and whole-cell patch-clamp electrophysiology, we examined the expression and role of STEP in regulating synaptic plasticity in rat BNSTALG neurons and its modulation by stress. RESULTS: Striatal-enriched protein tyrosine phosphatase was selectively expressed in CRF neurons in the oval nucleus of the BNSTALG. Following repeated restraint stress (RRS), animals displayed a significant increase in anxiety-like behavior, which was associated with a downregulation of STEP messenger RNA and protein expression in the BNSTALG, as well as selectively enhancing the magnitude of long-term potentiation (LTP) induced in Type III, putative CRF neurons. To determine if the changes in STEP expression following RRS were mechanistically related to LTP facilitation, we examined the effects of intracellular application of STEP on the induction of LTP. STEP completely blocked the RRS-induced facilitation of LTP in BNSTALG neurons. CONCLUSIONS: Hence, STEP acts to buffer CRF neurons against excessive activation, while downregulation of STEP after chronic stress may result in pathologic activation of CRF neurons in the BNSTALG and contribute to prolonged states of anxiety. Thus, targeted manipulations of STEP activity might represent a novel treatment strategy for stress-induced anxiety disorders.
BACKGROUND: Striatal-enriched protein tyrosine phosphatase (STEP) is a brain-specific protein tyrosine phosphatase that opposes the development of synaptic strengthening and the consolidation of fear memories. In contrast, stress facilitates fear memory formation, potentially by activating corticotrophin releasing factor (CRF) neurons in the anterolateral cell group of the bed nucleus of the stria terminalis (BNSTALG). METHODS: Here, using dual-immunofluorescence, single-cell reverse transcriptase polymerase chain reaction, quantitative reverse transcriptase polymerase chain reaction, Western blot, and whole-cell patch-clamp electrophysiology, we examined the expression and role of STEP in regulating synaptic plasticity in ratBNSTALG neurons and its modulation by stress. RESULTS: Striatal-enriched protein tyrosine phosphatase was selectively expressed in CRF neurons in the oval nucleus of the BNSTALG. Following repeated restraint stress (RRS), animals displayed a significant increase in anxiety-like behavior, which was associated with a downregulation of STEP messenger RNA and protein expression in the BNSTALG, as well as selectively enhancing the magnitude of long-term potentiation (LTP) induced in Type III, putative CRF neurons. To determine if the changes in STEP expression following RRS were mechanistically related to LTP facilitation, we examined the effects of intracellular application of STEP on the induction of LTP. STEP completely blocked the RRS-induced facilitation of LTP in BNSTALG neurons. CONCLUSIONS: Hence, STEP acts to buffer CRF neurons against excessive activation, while downregulation of STEP after chronic stress may result in pathologic activation of CRF neurons in the BNSTALG and contribute to prolonged states of anxiety. Thus, targeted manipulations of STEP activity might represent a novel treatment strategy for stress-induced anxiety disorders.
Keywords:
Anxiety; BNST; CRF; STEP; bed nucleus of the stria terminalis; chronic stress; corticotrophin releasing factor; striatal-enriched protein tyrosine phosphatase
Authors: Zoé A McElligott; Jason R Klug; William P Nobis; Sachin Patel; Brad A Grueter; Thomas L Kash; Danny G Winder Journal: Proc Natl Acad Sci U S A Date: 2010-01-19 Impact factor: 11.205
Authors: Surojit Paul; Peter Olausson; Deepa V Venkitaramani; Irina Ruchkina; Timothy D Moran; Natalie Tronson; Evan Mills; Shawn Hakim; Michael W Salter; Jane R Taylor; Paul J Lombroso Journal: Biol Psychiatry Date: 2006-11-01 Impact factor: 13.382
Authors: Dennis C Choi; Amy R Furay; Nathan K Evanson; Michelle M Ostrander; Yvonne M Ulrich-Lai; James P Herman Journal: J Neurosci Date: 2007-02-21 Impact factor: 6.167
Authors: Yongfang Zhang; Pradeep Kurup; Jian Xu; Nikisha Carty; Stephanie M Fernandez; Haakon B Nygaard; Christopher Pittenger; Paul Greengard; Stephen M Strittmatter; Angus C Nairn; Paul J Lombroso Journal: Proc Natl Acad Sci U S A Date: 2010-10-18 Impact factor: 11.205
Authors: S Bradley King; Kim R Lezak; Micaela O'Reilly; Donna J Toufexis; William A Falls; Karen Braas; Victor May; Sayamwong E Hammack Journal: Neuropsychopharmacology Date: 2017-01-20 Impact factor: 7.853
Authors: E R Hawken; C P Normandeau; J Gardner Gregory; B Cécyre; J-F Bouchard; K Mackie; É C Dumont Journal: Neuropsychopharmacology Date: 2019-01-07 Impact factor: 7.853
Authors: Oliver J Bosch; Joanna Dabrowska; Meera E Modi; Zachary V Johnson; Alaine C Keebaugh; Catherine E Barrett; Todd H Ahern; JiDong Guo; Valery Grinevich; Donald G Rainnie; Inga D Neumann; Larry J Young Journal: Psychoneuroendocrinology Date: 2015-11-23 Impact factor: 4.905